FDA approves first postpartum depression pill

The Food and Drug Administration approved the drug, called Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. It's taken once a day for 14 days.

How Virginians will benefit from postpartum depression pill

The FDA Approves First Postpartum Depression Pill

First Pill for Postpartum Depression Is Approved by FDA - WSJ

Health Watch: FDA approves first potential remedy for postpartum depression

FDA Approves First Oral Treatment for Postpartum Depression - US FDA

FDA approves first postpartum depression pill - The Economic Times

FDA Approves First Drug for Postpartum Depression

FDA approves Sage, Biogen drug for postpartum depression, but

FDA Approves Zurzuvae to Treat Postpartum Depression

Samantha Meltzer-Brody Featured in National News Following FDA Approval of First Postpartum Depression Treatment

Important Update: The US Food and Drug Administration has

FDA approved first pill for postpartum depression

FDA Approves First Pill To Treat Postpartum Depression - ACHI

FDA approves pill to treat postpartum depression, Lifestyles

My real postpartum body: the brutiful truth

Moms clapback over after shamers attack their postpartum bodies

A postpartum photo of 4 moms got thousands of negative comments

Postpartum bodies: The 'bounce back' isn't real—but fully

After the Baby's Birth: A Complete Guide for Postpartum Women